Disclosed herein are modulators of TRPV3 of formula (I)
wherein G
1
, X
1
, X
2
, X
3
, X
4
, X
5
, G
2
, Z
1
, R
a
, R
b
, u, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
Compounds of Formula I and Formula II are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula I and Formula II have the following structures:
where the definitions of the variables are provided herein.
Compounds of Formula I and Formula II are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula I and Formula II have the following structures:
where the definitions of the variables are provided herein.
Disclosed herein are modulators of TRPV3 of formula (I)
wherein G1, X1, X2, X3, X4, X5, G2, Z1, Ra, Rb, u, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.